| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970575 | The Journal of Heart and Lung Transplantation | 2013 | 8 Pages |
Abstract
Medication NA is an important problem in pediatric HT recipients and is associated with high mortality. Adolescent age, black race, Medicaid insurance and invasive hemodynamic support at transplant were associated with NA, whereas time on the wait list and gender were not. Targeted interventions among at-risk populations may be warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Melisa PsyD, Tajinder P. MD, MS, Kimberlee ScD, Christina J. MD, Heather J. NP, Christopher S. MD, MPH,